Allen Andersson - Director, Corcept Therapeutics Inc

As of May 11, 2009


Allen Andersson Net Worth

  • Net worth is estimated to be at least $183.35M
  • Owns at least 306,837 units of Corcept Therapeutics Inc stock
  • Sold an estimated value of $8.14M in the last 2 years at Corcept Therapeutics Inc

Allen Andersson Trading

  • Largest purchase of shares was 2,118,270 units , worth over $5.87M on March 28, 2008
  • Largest sale of shares was 10,914,507 units , worth over $7.51M on February 10, 2009
  • In total has made about 23 transactions over 2 years
  • Usually trades in November, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Allen Andersson Mailing Address

  • Mailing address is 62 Sparhawk Lane North Conway NH 20817 NH

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 $ $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 $ $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 $ $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 $ $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 $ $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 $ $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 $ $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 $ $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 $ $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

Corcept Therapeutics Inc Insider Trading

  • The most recent transaction was 35,000 units sold on May 19, 2022 by Gary Charles worth over $684.4K
  • In the last 18 years, insiders at Corcept Therapeutics Inc sold an estimated value of $163.14M and bought an estimated value of $183.48M
  • The most active traders are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director
  • Insider trading is most common in February, with the busiest year in 2006

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1